Cancer medicines

Apalutamide

Apalutamide

An androgen receptor inhibitor used in selected prostate cancers.

Sources checked · Introductory guide

On this page

How it works

It blocks androgen receptor signaling to suppress cancer cell growth.[3]

Where it is used

Used in selected nonmetastatic castration-resistant or metastatic castration-sensitive prostate cancers.[1]

Key safety points

Discuss rash, falls and fracture risk. Blistering rash, mucosal sores, seizures or new breathlessness need urgent care.[2]

Questions for your care team

  • What is the plan for androgen deprivation and skin, bone and thyroid monitoring?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Apalutamide (opens in a new tab)
  2. MedlinePlus · Apalutamide (opens in a new tab)
  3. NCI Drug Dictionary · Apalutamide (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Apalutamide | Cancer Encyclopedia | My Chemo Diary